Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$4.8M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 3 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 22 most recent Form 4 transactions.
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 2,566 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 2,241 | — | — | — | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | FTAX | 5,378 | $124.12 | $667.5K | -3.4% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | AGRANT | 9,968 | — | — | +6.8% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | FTAX | 1,385 | $124.12 | $171.9K | -0.9% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER | 2,566 | — | — | +1.8% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | FTAX | 1,210 | $124.12 | $150.2K | -0.8% | Open the original filing on SEC.gov |
| Feb 13 | NBIX | Neurocrine Biosciences INC | MEXER | 2,241 | — | — | +1.6% | Open the original filing on SEC.gov |
| Feb 12 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 4,907 | — | — | — | Open the original filing on SEC.gov |
| Feb 12 | NBIX | Neurocrine Biosciences INC | FTAX | 2,648 | $123.10 | $326K | -1.8% | Open the original filing on SEC.gov |
| Feb 12 | NBIX | Neurocrine Biosciences INC | MEXER | 4,907 | — | — | +3.5% | Open the original filing on SEC.gov |
| Jan 31 | NBIX | Neurocrine Biosciences INC | MEXER◆ | 2,927 | — | — | — | Open the original filing on SEC.gov |
| Jan 31 | NBIX | Neurocrine Biosciences INC | FTAX | 1,580 | $136.06 | $215K | -1.1% | Open the original filing on SEC.gov |
| Jan 31 | NBIX | Neurocrine Biosciences INC | MEXER | 2,927 | — | — | +2.1% | Open the original filing on SEC.gov |
| Jan 16 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 1,812 | — | — | — | Open the original filing on SEC.gov |
| Jan 16 | NBIX | Neurocrine Biosciences INC | MEXER◷◆ | 34,588 | — | — | — | Open the original filing on SEC.gov |
| Jan 16 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 1,812 | $132.71 | $240.5K | -1.3% | Open the original filing on SEC.gov |
| Jan 16 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 1,812 | $35.99 | $65.2K | +1.3% | Open the original filing on SEC.gov |
| Jan 16 | NBIX | Neurocrine Biosciences INC | SSELL◷ | 34,588 | $132.70 | $4.6M | -19.8% | Open the original filing on SEC.gov |
| Jan 16 | NBIX | Neurocrine Biosciences INC | MEXER◷ | 34,588 | $35.99 | $1.2M | +24.6% | Open the original filing on SEC.gov |